Adenovirus Vaccine Vectors and HIV Acquisition Risk: The View from the Summit
On September 19th, 2013, the National Institute of Allergy and Infectious Diseases (NIAID) sponsored a daylong mini-summit to discuss the safety of adenovirus vaccine vectors in populations at risk for HIV infection.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
